Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups

Journal of the American Dietetic Association

Volumn 103, Issue 2, 2003, Pages 200-207

  Esfahani, Setareh Torabian ^a,b   Cogger, Edward A ^a   Caudill, Marie A ^a  

^a CALIFORNIA STATE POLYTECHNIC UNIVERSITY   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASE;

ADULT; AFRICAN AMERICAN; AMINO ACID ANALYSIS; ANALYSIS OF VARIANCE; ARTICLE; ASIAN; BLOOD SAMPLING; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; FOLIC ACID BLOOD LEVEL; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOSITY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; STUDENT T TEST; VITAMIN SUPPLEMENTATION; ADOLESCENT; AGED; ASIAN AMERICAN; BLOOD; ETHNIC GROUP; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; MIDDLE AGED; MUTATION; NEGRO; NUTRITIONAL REQUIREMENT; RACE; STATISTICS;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ASIAN AMERICANS; ASIAN CONTINENTAL ANCESTRY GROUP; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLIC ACID; GENE FREQUENCY; GENETIC HETEROGENEITY; GENOTYPE; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MEXICAN AMERICANS; MIDDLE AGED; MUTATION; NUTRITIONAL REQUIREMENTS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; PREVALENCE;

EID: 0037313390     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1053/jada.2003.50030     Document Type: Article

References (60)

1. m): relevance to genetic disease and polymorphisms. AM J CLIN NUTR. 75:2002;616-658.
2. Bailey L.B., Gregory J.F. III. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J NUTR. 129:1999;919-922.
3. Ueland P.M., Hustad S., Schneede J., Refsum H., Vollset S.E. Biological and clinical implications of the MTHFR C677T polymorphism. TRENDS PHARMACOL SCI. 22:2001;195-201.
4. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J.H., den Heijer M., Kluijtmans L.A.J., van den Heuvel L.P., Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase (Letter). NAT GENET. 10:1995;111-113.
5. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J., Rosen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. CIRCULATION. 93:1996;7-9.
6. Christensen B., Arbour L., Tran P., Leclerc D., Sabbaghian N., Platt R., Gilfix B.M., Rosenblatt D.S., Gravel R.A., Forbes P., Rozen R. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. AM J MED GENET. 84:1999;151-157.
7. Botto L.D., Yang Q. 5-10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. AM J EPIDEMIOL. 151:2000;862-877.
8. van der Put N.M.J., Blom H.J. Neural tube defects and disturbed folate dependent homocysteine metabolism. EUR J OBSTET GYNECOL REPROD BIOL. 92:2000;57-61.
9. James S.J., Pogribna M., Pogribny I.P., Melnyk S., Hine R.J., Gibson J.B., Ping Y., Tafoya D.L., Swenson D.H., Wilson V.L., Gaylor D.W. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. AM J CLIN NUTR. 70:1999;495-501.
10. Hobbs C.A., Sherman S.L., Ping Y., Hopkins S.E., Torfs C.P., Hine R.J., Pogribna M., Rozen R., James S.J. Polymorphisms in genes in folate metabolism as maternal risk factors for Down syndrome. AM J HUM GENET. 67:2000;623-630.
11. Esteller M., Garcia A.N., Martinez-Palones J.M., Xercavins J., Reventos J. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. CARCINOGENESIS. 18:1997;2307-2311.
12. Viel A., Agnese L.D., Simine F., Canzonieri V., Capozzi E., Visentin M.C., Valle R., Boiocchi M. Loss of heterozygosity at the 5,10 methylenetetrahydrofolate reductase locus in human ovarian carcinomas. BR J CANCER. 75:1997;1105-1110.
13. Ulrich C.M., Kampman E., Bigler J., Schwartz S.M., Chen C., Bostick R., Fosdick L., Beresford S.A.A., Yasui Y., Potter J.D. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? CANCER EPIDEMIOL BIOMARKERS PREV. 8:1999;659-668.
14. Piyathilake C.J., Macaluso M., Johanning G.L., Whiteside M., Heimburger D.C., Giuliano A. Methylenetetrahydrofolate (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. ANTICANCER RES. 20:2000;1751-1758.
15. Shen H., Xu Y., Zheng Y., Qian Y., Yu R., Qin Y., Wang X., Spitz M.R., Wei Q. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. INT J CANCER. 95:2001;332-336.
16. Shannon B., Gnanasampanthan S., Beilby J., Iacopetta B. A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. GUT. 50:2002;520-524.
17. Ma J., Stampfer M.J., Giovannucci E., Artigas C., Hunter D.J., Fuchs C., Willett W.C., Selhub J., Hennekens C.H., Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. CANCER RES. 57:1997;1098-1102.
18. Chen J., Giovannucci E.L., Hunter D.J. MTHFR polymorphism, methyl-replete diets and risk of colorectal carcinoma and adenoma among US men and women: an example of gene-environment interactions in colorectal tumorigenesis. J NUTR. 129:1999;560S-564S.
19. Skibola C.F., Smith M.T., Kane E., Roman E., Rollinson S., Cartwright R.A., Morgan G. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. PROC NATL ACAD SCI U S A. 96:1999;12810-12815.
20. Matsuo K., Suzuki R., Hamajima N., Ogura M., Kagami Y., Taji H., Kondoh E., Maeda S., Asakura S., Kaba S., Nakamura S., Seto M., Morishima Y., Tajima K. Association between polymorphisms of folate-and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. BLOOD. 97:2001;3205-3209.
21. Kauwell G.P., Wilsky C.E., Cerda J.J., Herrlinger-Garcia K., Hutson A.D., Theriaque D.W., Boddie A., Rampersaud G.C., Bailey L.B. Methylenetetrahydrofolate reductase mutation (C677→T) negatively influences plasma homocysteine response to marginal folate intake in elderly women. METABOLISM. 49:2000;1440-1443.
22. Yates A.A., Schlicker S.A., Suitor C.W. Dietary reference intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline. J AM DIET ASSOC. 98:1998;699-706.
23. Bailey L.B., Suitor C.W. Dietary folate equivalents: interpretation and application. J AM DIET ASSOC. 100:2000;88-94.
24. McAndrew P.E., Brandt J.T., Pearl D.K., Prior T.W. The incidence of the gene for thermolabile methylenetetrahydrofolate reductase in African Americans. THROMB RES. 83:1996;195-198.
25. Stevenson R.E., Schwartz C.E., Du Y.Z., Adams M.J. Jr. Differences in methylenetetrahydrofolate reductase genotype frequencies between Whites and Blacks (Letter). AM J HUM GENET. 60:1997;229-230.
26. Shaw G.M., Rozen R., Finnell R.H., Wasserman C.R., Lammer E.J. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate, and risk for spina bifida. AM J EPIDEMIOL. 148:1998;30-37.
27. Caudill M.A., Le T., Moonie S.A., Torabian Esfahani S., Cogger E.A. Folate status in women of childbearing age residing in Southern California after folic acid fortification. J AM COLL NUTR. 20:2001;129-134.
28. van der Put N.M.J., Gabreëls F., Stevens E.M.B., Smeitink J.A.M., Trijbels F.J.M., Eskes TKAB, van den Heuvel L.P., Blom H.J. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects? AM J HUM GENET. 62:1998;1044-1051.
29. Weisberg I., Tran P., Christensen B., Sibani S., Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. MOL GENET METAB. 64:1998;169-172.
30. Chango A., Boisson F., Barbé F., Quilliot D., Droesch S., Pfister M., Fillon-Emery N., Lambert D., Frémont S., Rosenblatt D.S., Nicolas J.P. The effect of the 677C→T and 1298A→C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. BR J NUTR. 83:2000;593-596.
31. Friedman G., Goldschmidt N., Friedlander Y., Ben-Yehuda A., Selhub J., Babaey S., Mendel M., Kidron M., Bar-On H. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J NUTR. 129:1999;1656-1661.
32. Hanson N.Q., Aras O., Yang F., Tsai M.Y. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. CLIN CHEM. 47:2001;661-666.
33. Lievers K.J.A., Boers G.H.J., Verhoef P., den Heijer M., Kluijtmans L.A.J., van der Put N.M.J., Trijbels F.J.M., Blom H.J. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular risk. J MOL MED. 79:2001;522-528.
34. Dekou V., Whincup P., Papacosta O., Ebrahim S., Lennon L., Ueland P.M., Refsum H., Humphries S.E., Gudnason V. The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study. ATHEROSCLEROSIS. 154:2001;659-666.
35. Weisberg I.S., Jacques P.F., Selhub J., Bostom A.G., Chen Z., Ellison R.C., Eckfeldt J.H., Rozen R. The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. ATHEROSCLEROSIS. 156:2001;409-415.
36. Szczeklik A., Sanak M., Jankowski M., Dropinski J., Czachór R., Musial J., Axenti I., Twardowska M., Brzostek T., Tendera M. Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocysteinemia. AM J MED GENET. 101:2001;36-39.
37. Richter B., Stegmann K., Röper B., Böddeker I., Ngo ETKM, Koch M.C. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population. J HUM GENET. 46:2001;105-109.
38. Gebhardt G.S., Scholtz C.L., Hillermann R., Odendaal H.J. Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentia but not with intrauterine growth restriction. EUR J OBSTET GYNECOL REPROD BIOL. 97:2001;174-177.
39. Zetterberg H., Regland B., Palmer M., Ricksten A., Palmqvist L., Rymo L., Arvanitis D.A., Spandidos D.A., Blennow K. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. EUR J HUM GENET. 10:2002;113-118.
40. Song C., Xing D., Tan W., Wei Q., Lin D. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. CANCER RES. 61:2001;3272-3275.
41. Rady P.L., Tyring S.K., Hudnall S.D., Vargas T., Kellner L.H., Nitowsky H., Matalon R.K. Methylenetetrahydrofolate reductase (MTHFR): the incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. AM J MED GENET. 86:1999;380-384.
42. Tamura T. Microbiological assay of folates. Picciano M.F., Stokstad E.L.R., Gregory J.F. FOLIC ACID METABOLISM IN HEALTH AND DISEASE. 1990;121-137 John Wiley & Sons, New York.
43. Vester B., Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. EUR J CLIN CHEM CLIN BIOCHEM. 29:1991;549-554.
44. Pfeiffer C.M., Huff D.L., Gunter E.W. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical setting. CLIN CHEM. 45:1999;290-292.
45. van der Put N.M.J., Blom H.J. Reply to Donnelly (Letter). AM J HUM GENET. 66:2000;744-745.
46. Schneider J.A., Rees D.C., Liu Y.T., Clegg J.B. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation (Letter). AM J HUM GENET. 62:1998;1258-1260.
47. Pepe G., Vanegas O.C., Giusti B., Brunelli T., Marcucci R., Attansio M., Rickards O., De Stefano G.F., Prisco D., Gensini G.F., Abbate R. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10- methylenetetrahydrofolate reductase (Letter). AM J HUM GENET. 63:1998;917-920.
48. Rozen R., Fraser F.C., Shaw G. Decreased proportion of female newborn infants homozygous for the 677 C→T mutation in methylenetetrahydrofolate reductase (Letter). AM J MED GENET. 83:1999;142-143.
49. Peng F., Labelle L.A., Rainey B.J., Tsongalis G.J. Single nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene are common in US Caucasian and Hispanic American populations. INT J MOL MED. 8:1999;509-511.
50. Isotalo P.A., Wells G.A., Donnelly J.G. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. AM J HUM GENET. 67:2000;986-990.
51. Meisel C., Cascorbi I., Gerloff T., Stangl V., Laule M., Müller J.M., Wernecke K.D., Baumann G., Roots I., Stangl K. Identification of six methylenetetrahydrofolate reductase (MTHFR) genotypes resulting from common polymorphisms: impact on plasma homocysteine levels and development of coronary artery disease. ATHEROSCLEROSIS. 154:2001;651-658.
52. Jacques P.F., Selhub J., Bostom A.G., Wilson P.W., Rosenberg I.H. The effect of folic acid fortification on plasma folate and total homocysteine concentration. N ENGL J MED. 340:1999;1449-1454.
53. Lawrence J.M., Petitti D.B., Watkins M., Umekubo M.A. Trends in serum folate after food fortification (Letter). LANCET. 354:1999;915-916.
54. Folate status in women of childbearing age-United States, 1999. MMWR MORB MORTAL WKLY REP. 49:2000;962-965.
55. Guenther B.D., Sheppard C.A., Tran P., Rozen R., Matthews R.G., Ludwig M.L. The structure and properties of methylenetetrahydrofolate reductase from ESCHERICHIA COLI suggest how folate ameliorates human hyperhomocysteinemia. NAT STRUCT BIOL. 6:1999;359-365.
56. Rozen R. Molecular genetics of methylenetetrahydrofolate reductase deficiency. J INHER METAB DIS. 19:1996;589-594.
57. Friso S., Choi S.W., Girelli D., Mason J.B., Dolnikowski G.G., Bagley P.J., Olivieri O., Jacques P.F., Rosenberg I.H., Corrocher R., Selhub J. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. PROC NATL ACAD SCI U S A. 99:2002;5606-5611.
58. Feuchtbaum L.B., Currier R.J., Riggle S., Roberson M., Lorey F.W., Cunningham G.C. Neural tube defect prevalence in California (1990-1994): eliciting patterns by type of defect and maternal race/ethnicity. GENET TEST. 3:1999;265-272.
59. Ford E.S., Bowman B.A. Serum and red blood cell folate concentrations, race, and education: findings from the third National Health and Nutrition Examination Survey. AM J CLIN NUTR. 69:1999;476-481.
60. Young V.R. Human nutrient requirements: The challenge of the post-genome era. J NUTR. 132:2002;621-629.